nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—HTR1A—stomach cancer	0.44	1	CbGaD
Trimipramine—ABCB1—Mitomycin—stomach cancer	0.0661	0.347	CbGbCtD
Trimipramine—CYP2C9—Capecitabine—stomach cancer	0.0283	0.148	CbGbCtD
Trimipramine—ABCB1—Irinotecan—stomach cancer	0.017	0.0889	CbGbCtD
Trimipramine—CYP2C9—Fluorouracil—stomach cancer	0.0168	0.0879	CbGbCtD
Trimipramine—HTR3A—myenteric nerve plexus—stomach cancer	0.0156	0.193	CbGeAlD
Trimipramine—ABCB1—Docetaxel—stomach cancer	0.0124	0.0652	CbGbCtD
Trimipramine—HTR3A—vagus nerve—stomach cancer	0.0104	0.129	CbGeAlD
Trimipramine—CYP3A4—Irinotecan—stomach cancer	0.0102	0.0533	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—stomach cancer	0.00927	0.0486	CbGbCtD
Trimipramine—ABCB1—Methotrexate—stomach cancer	0.00898	0.0471	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—stomach cancer	0.00873	0.0458	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—stomach cancer	0.00745	0.0391	CbGbCtD
Trimipramine—HTR2A—myenteric nerve plexus—stomach cancer	0.00631	0.0781	CbGeAlD
Trimipramine—CYP3A4—Doxorubicin—stomach cancer	0.00555	0.0291	CbGbCtD
Trimipramine—HTR2A—vagus nerve—stomach cancer	0.00421	0.0521	CbGeAlD
Trimipramine—HTR2A—vein—stomach cancer	0.00407	0.0503	CbGeAlD
Trimipramine—HTR1D—blood vessel—stomach cancer	0.0026	0.0321	CbGeAlD
Trimipramine—HTR3A—hematopoietic system—stomach cancer	0.0017	0.0211	CbGeAlD
Trimipramine—SLC6A3—hematopoietic system—stomach cancer	0.00142	0.0175	CbGeAlD
Trimipramine—SLC6A4—hematopoietic system—stomach cancer	0.0013	0.0161	CbGeAlD
Trimipramine—HTR2A—blood vessel—stomach cancer	0.00129	0.016	CbGeAlD
Trimipramine—HTR3A—digestive system—stomach cancer	0.00118	0.0147	CbGeAlD
Trimipramine—HTR1A—hematopoietic system—stomach cancer	0.00115	0.0143	CbGeAlD
Trimipramine—CYP2C19—hematopoietic system—stomach cancer	0.00108	0.0133	CbGeAlD
Trimipramine—ADRA1A—hematopoietic system—stomach cancer	0.00106	0.0131	CbGeAlD
Trimipramine—ADRA1A—epithelium—stomach cancer	0.000972	0.012	CbGeAlD
Trimipramine—SLC6A4—digestive system—stomach cancer	0.000904	0.0112	CbGeAlD
Trimipramine—ABCB1—blood vessel—stomach cancer	0.000846	0.0105	CbGeAlD
Trimipramine—CYP2C9—hematopoietic system—stomach cancer	0.000835	0.0103	CbGeAlD
Trimipramine—HRH1—hematopoietic system—stomach cancer	0.000823	0.0102	CbGeAlD
Trimipramine—ADRA2A—hematopoietic system—stomach cancer	0.000809	0.01	CbGeAlD
Trimipramine—HRH1—epithelium—stomach cancer	0.000752	0.0093	CbGeAlD
Trimipramine—CYP2C19—digestive system—stomach cancer	0.000749	0.00926	CbGeAlD
Trimipramine—ADRA1A—lymphoid tissue—stomach cancer	0.000749	0.00926	CbGeAlD
Trimipramine—SLC6A4—endocrine gland—stomach cancer	0.000747	0.00923	CbGeAlD
Trimipramine—HRH1—smooth muscle tissue—stomach cancer	0.000725	0.00896	CbGeAlD
Trimipramine—Mianserin—HRH4—stomach cancer	0.000704	0.11	CrCbGaD
Trimipramine—HTR2A—hematopoietic system—stomach cancer	0.000688	0.0085	CbGeAlD
Trimipramine—HTR1A—endocrine gland—stomach cancer	0.000663	0.0082	CbGeAlD
Trimipramine—ADRA2A—pancreas—stomach cancer	0.000658	0.00814	CbGeAlD
Trimipramine—SLC6A2—endocrine gland—stomach cancer	0.000657	0.00813	CbGeAlD
Trimipramine—CYP3A4—hematopoietic system—stomach cancer	0.000636	0.00787	CbGeAlD
Trimipramine—HTR2A—epithelium—stomach cancer	0.000628	0.00777	CbGeAlD
Trimipramine—CYP2D6—hematopoietic system—stomach cancer	0.000626	0.00774	CbGeAlD
Trimipramine—CYP2C19—endocrine gland—stomach cancer	0.000619	0.00765	CbGeAlD
Trimipramine—ADRA1A—endocrine gland—stomach cancer	0.000611	0.00755	CbGeAlD
Trimipramine—HTR2A—smooth muscle tissue—stomach cancer	0.000606	0.00749	CbGeAlD
Trimipramine—DRD2—endocrine gland—stomach cancer	0.000599	0.00741	CbGeAlD
Trimipramine—CYP2C9—digestive system—stomach cancer	0.00058	0.00718	CbGeAlD
Trimipramine—Benazepril—MTHFR—stomach cancer	0.000573	0.0896	CrCbGaD
Trimipramine—HRH1—digestive system—stomach cancer	0.000572	0.00708	CbGeAlD
Trimipramine—Promethazine—HRH4—stomach cancer	0.00057	0.0892	CrCbGaD
Trimipramine—Doxepin—HRH4—stomach cancer	0.000564	0.0883	CrCbGaD
Trimipramine—CYP2C19—liver—stomach cancer	0.000558	0.0069	CbGeAlD
Trimipramine—ADRA1A—liver—stomach cancer	0.000551	0.00681	CbGeAlD
Trimipramine—CYP2C9—endocrine gland—stomach cancer	0.00048	0.00593	CbGeAlD
Trimipramine—HTR2A—digestive system—stomach cancer	0.000478	0.00591	CbGeAlD
Trimipramine—HRH1—endocrine gland—stomach cancer	0.000473	0.00585	CbGeAlD
Trimipramine—Benazepril—ACE—stomach cancer	0.000467	0.0731	CrCbGaD
Trimipramine—ADRA2A—endocrine gland—stomach cancer	0.000465	0.00574	CbGeAlD
Trimipramine—SLC6A2—lymph node—stomach cancer	0.000454	0.00562	CbGeAlD
Trimipramine—ABCB1—hematopoietic system—stomach cancer	0.000451	0.00557	CbGeAlD
Trimipramine—CYP3A4—digestive system—stomach cancer	0.000443	0.00547	CbGeAlD
Trimipramine—Chlorpromazine—HRH4—stomach cancer	0.000442	0.0691	CrCbGaD
Trimipramine—Amitriptyline—HRH4—stomach cancer	0.000437	0.0683	CrCbGaD
Trimipramine—CYP2D6—digestive system—stomach cancer	0.000436	0.00538	CbGeAlD
Trimipramine—CYP2C9—liver—stomach cancer	0.000432	0.00535	CbGeAlD
Trimipramine—ABCB1—epithelium—stomach cancer	0.000412	0.00509	CbGeAlD
Trimipramine—HTR2A—endocrine gland—stomach cancer	0.000395	0.00488	CbGeAlD
Trimipramine—ABCB1—pancreas—stomach cancer	0.000367	0.00454	CbGeAlD
Trimipramine—CYP3A4—endocrine gland—stomach cancer	0.000366	0.00452	CbGeAlD
Trimipramine—CYP2D6—endocrine gland—stomach cancer	0.00036	0.00445	CbGeAlD
Trimipramine—HTR2A—liver—stomach cancer	0.000356	0.0044	CbGeAlD
Trimipramine—Purpura—Doxorubicin—stomach cancer	0.000338	0.0022	CcSEcCtD
Trimipramine—Insomnia—Irinotecan—stomach cancer	0.000336	0.00219	CcSEcCtD
Trimipramine—Flushing—Docetaxel—stomach cancer	0.000335	0.00219	CcSEcCtD
Trimipramine—Paraesthesia—Irinotecan—stomach cancer	0.000333	0.00217	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000332	0.00217	CcSEcCtD
Trimipramine—Hypotension—Fluorouracil—stomach cancer	0.000332	0.00217	CcSEcCtD
Trimipramine—Ataxia—Epirubicin—stomach cancer	0.000331	0.00216	CcSEcCtD
Trimipramine—Somnolence—Irinotecan—stomach cancer	0.00033	0.00215	CcSEcCtD
Trimipramine—CYP3A4—liver—stomach cancer	0.00033	0.00408	CbGeAlD
Trimipramine—HRH1—lymph node—stomach cancer	0.000327	0.00404	CbGeAlD
Trimipramine—Dyspepsia—Irinotecan—stomach cancer	0.000327	0.00213	CcSEcCtD
Trimipramine—Tinnitus—Capecitabine—stomach cancer	0.000326	0.00213	CcSEcCtD
Trimipramine—CYP2D6—liver—stomach cancer	0.000324	0.00401	CbGeAlD
Trimipramine—Flushing—Capecitabine—stomach cancer	0.000324	0.00212	CcSEcCtD
Trimipramine—Decreased appetite—Irinotecan—stomach cancer	0.000323	0.0021	CcSEcCtD
Trimipramine—Arrhythmia—Docetaxel—stomach cancer	0.000323	0.0021	CcSEcCtD
Trimipramine—Eosinophilia—Methotrexate—stomach cancer	0.000322	0.0021	CcSEcCtD
Trimipramine—Insomnia—Fluorouracil—stomach cancer	0.000321	0.0021	CcSEcCtD
Trimipramine—ADRA2A—lymph node—stomach cancer	0.000321	0.00397	CbGeAlD
Trimipramine—Fatigue—Irinotecan—stomach cancer	0.00032	0.00209	CcSEcCtD
Trimipramine—Paraesthesia—Fluorouracil—stomach cancer	0.000319	0.00208	CcSEcCtD
Trimipramine—Alopecia—Docetaxel—stomach cancer	0.000319	0.00208	CcSEcCtD
Trimipramine—Constipation—Irinotecan—stomach cancer	0.000317	0.00207	CcSEcCtD
Trimipramine—ABCB1—lymphoid tissue—stomach cancer	0.000317	0.00392	CbGeAlD
Trimipramine—Somnolence—Fluorouracil—stomach cancer	0.000316	0.00206	CcSEcCtD
Trimipramine—ABCB1—digestive system—stomach cancer	0.000313	0.00387	CbGeAlD
Trimipramine—Dyspepsia—Fluorouracil—stomach cancer	0.000313	0.00204	CcSEcCtD
Trimipramine—Arrhythmia—Capecitabine—stomach cancer	0.000312	0.00204	CcSEcCtD
Trimipramine—Decreased appetite—Fluorouracil—stomach cancer	0.000309	0.00201	CcSEcCtD
Trimipramine—Alopecia—Capecitabine—stomach cancer	0.000309	0.00201	CcSEcCtD
Trimipramine—Pancytopenia—Methotrexate—stomach cancer	0.000309	0.00201	CcSEcCtD
Trimipramine—Dysgeusia—Docetaxel—stomach cancer	0.000308	0.00201	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—stomach cancer	0.000306	0.002	CcSEcCtD
Trimipramine—Feeling abnormal—Irinotecan—stomach cancer	0.000306	0.00199	CcSEcCtD
Trimipramine—Eosinophilia—Epirubicin—stomach cancer	0.000301	0.00196	CcSEcCtD
Trimipramine—Erectile dysfunction—Methotrexate—stomach cancer	0.000299	0.00195	CcSEcCtD
Trimipramine—Dysgeusia—Capecitabine—stomach cancer	0.000298	0.00194	CcSEcCtD
Trimipramine—Clomipramine—GSTP1—stomach cancer	0.000296	0.0464	CrCbGaD
Trimipramine—Abdominal pain—Irinotecan—stomach cancer	0.000293	0.00191	CcSEcCtD
Trimipramine—Body temperature increased—Irinotecan—stomach cancer	0.000293	0.00191	CcSEcCtD
Trimipramine—Feeling abnormal—Fluorouracil—stomach cancer	0.000293	0.00191	CcSEcCtD
Trimipramine—Drowsiness—Methotrexate—stomach cancer	0.00029	0.00189	CcSEcCtD
Trimipramine—Pancytopenia—Epirubicin—stomach cancer	0.000289	0.00188	CcSEcCtD
Trimipramine—ABCB1—bone marrow—stomach cancer	0.000289	0.00357	CbGeAlD
Trimipramine—Vision blurred—Capecitabine—stomach cancer	0.000287	0.00187	CcSEcCtD
Trimipramine—Tremor—Capecitabine—stomach cancer	0.000285	0.00186	CcSEcCtD
Trimipramine—Stomatitis—Methotrexate—stomach cancer	0.000283	0.00184	CcSEcCtD
Trimipramine—Ill-defined disorder—Capecitabine—stomach cancer	0.000282	0.00184	CcSEcCtD
Trimipramine—Urticaria—Fluorouracil—stomach cancer	0.000282	0.00184	CcSEcCtD
Trimipramine—Pollakiuria—Epirubicin—stomach cancer	0.000281	0.00183	CcSEcCtD
Trimipramine—Body temperature increased—Fluorouracil—stomach cancer	0.000281	0.00183	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—stomach cancer	0.000279	0.00182	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—stomach cancer	0.000278	0.00181	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—stomach cancer	0.000277	0.00181	CcSEcCtD
Trimipramine—Malaise—Capecitabine—stomach cancer	0.000274	0.00179	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—stomach cancer	0.000272	0.00178	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—stomach cancer	0.000271	0.00177	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—stomach cancer	0.000271	0.00177	CcSEcCtD
Trimipramine—Agranulocytosis—Methotrexate—stomach cancer	0.000271	0.00176	CcSEcCtD
Trimipramine—Palpitations—Capecitabine—stomach cancer	0.000269	0.00175	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—stomach cancer	0.000267	0.00174	CcSEcCtD
Trimipramine—Asthenia—Irinotecan—stomach cancer	0.000266	0.00174	CcSEcCtD
Trimipramine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000266	0.00173	CcSEcCtD
Trimipramine—Stomatitis—Epirubicin—stomach cancer	0.000264	0.00172	CcSEcCtD
Trimipramine—Jaundice—Epirubicin—stomach cancer	0.000264	0.00172	CcSEcCtD
Trimipramine—Hypertension—Capecitabine—stomach cancer	0.000263	0.00171	CcSEcCtD
Trimipramine—Dry mouth—Docetaxel—stomach cancer	0.000262	0.00171	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—stomach cancer	0.00026	0.0017	CcSEcCtD
Trimipramine—ABCB1—endocrine gland—stomach cancer	0.000259	0.0032	CbGeAlD
Trimipramine—Confusional state—Docetaxel—stomach cancer	0.000259	0.00169	CcSEcCtD
Trimipramine—Anxiety—Capecitabine—stomach cancer	0.000258	0.00168	CcSEcCtD
Trimipramine—Oedema—Docetaxel—stomach cancer	0.000257	0.00167	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—stomach cancer	0.000256	0.00167	CcSEcCtD
Trimipramine—Discomfort—Capecitabine—stomach cancer	0.000256	0.00167	CcSEcCtD
Trimipramine—Diarrhoea—Irinotecan—stomach cancer	0.000254	0.00166	CcSEcCtD
Trimipramine—Dry mouth—Capecitabine—stomach cancer	0.000253	0.00165	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—stomach cancer	0.000253	0.00165	CcSEcCtD
Trimipramine—Pruritus—Fluorouracil—stomach cancer	0.000251	0.00164	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—stomach cancer	0.000251	0.00164	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—stomach cancer	0.000251	0.00164	CcSEcCtD
Trimipramine—Confusional state—Capecitabine—stomach cancer	0.00025	0.00163	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—stomach cancer	0.00025	0.00163	CcSEcCtD
Trimipramine—Oedema—Capecitabine—stomach cancer	0.000248	0.00162	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000246	0.0016	CcSEcCtD
Trimipramine—Dizziness—Irinotecan—stomach cancer	0.000245	0.0016	CcSEcCtD
Trimipramine—Acepromazine—HTR1A—stomach cancer	0.000245	0.0383	CrCbGaD
Trimipramine—Jaundice—Doxorubicin—stomach cancer	0.000245	0.0016	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—stomach cancer	0.000245	0.0016	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—stomach cancer	0.000245	0.00159	CcSEcCtD
Trimipramine—Diarrhoea—Fluorouracil—stomach cancer	0.000243	0.00159	CcSEcCtD
Trimipramine—Thrombocytopenia—Capecitabine—stomach cancer	0.000243	0.00159	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—stomach cancer	0.000243	0.00158	CcSEcCtD
Trimipramine—Tachycardia—Capecitabine—stomach cancer	0.000242	0.00158	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—stomach cancer	0.000242	0.00158	CcSEcCtD
Trimipramine—Hypotension—Docetaxel—stomach cancer	0.00024	0.00156	CcSEcCtD
Trimipramine—Anorexia—Capecitabine—stomach cancer	0.000237	0.00154	CcSEcCtD
Trimipramine—Vomiting—Irinotecan—stomach cancer	0.000236	0.00154	CcSEcCtD
Trimipramine—Dizziness—Fluorouracil—stomach cancer	0.000235	0.00153	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—stomach cancer	0.000234	0.00153	CcSEcCtD
Trimipramine—Rash—Irinotecan—stomach cancer	0.000234	0.00153	CcSEcCtD
Trimipramine—Dermatitis—Irinotecan—stomach cancer	0.000234	0.00152	CcSEcCtD
Trimipramine—ABCB1—liver—stomach cancer	0.000233	0.00289	CbGeAlD
Trimipramine—Headache—Irinotecan—stomach cancer	0.000232	0.00152	CcSEcCtD
Trimipramine—Hypotension—Capecitabine—stomach cancer	0.000232	0.00151	CcSEcCtD
Trimipramine—Insomnia—Docetaxel—stomach cancer	0.000232	0.00151	CcSEcCtD
Trimipramine—Paraesthesia—Docetaxel—stomach cancer	0.00023	0.0015	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—stomach cancer	0.00023	0.0015	CcSEcCtD
Trimipramine—Somnolence—Docetaxel—stomach cancer	0.000228	0.00149	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—stomach cancer	0.000227	0.00148	CcSEcCtD
Trimipramine—Flushing—Epirubicin—stomach cancer	0.000226	0.00147	CcSEcCtD
Trimipramine—Vomiting—Fluorouracil—stomach cancer	0.000226	0.00147	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—stomach cancer	0.000226	0.00147	CcSEcCtD
Trimipramine—Insomnia—Capecitabine—stomach cancer	0.000225	0.00146	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000224	0.00146	CcSEcCtD
Trimipramine—Rash—Fluorouracil—stomach cancer	0.000224	0.00146	CcSEcCtD
Trimipramine—Dermatitis—Fluorouracil—stomach cancer	0.000224	0.00146	CcSEcCtD
Trimipramine—Paraesthesia—Capecitabine—stomach cancer	0.000223	0.00145	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—stomach cancer	0.000223	0.00145	CcSEcCtD
Trimipramine—Headache—Fluorouracil—stomach cancer	0.000223	0.00145	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—stomach cancer	0.000222	0.00145	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—stomach cancer	0.000221	0.00144	CcSEcCtD
Trimipramine—Nausea—Irinotecan—stomach cancer	0.00022	0.00144	CcSEcCtD
Trimipramine—Constipation—Docetaxel—stomach cancer	0.000219	0.00143	CcSEcCtD
Trimipramine—Dyspepsia—Capecitabine—stomach cancer	0.000219	0.00143	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—stomach cancer	0.000218	0.00142	CcSEcCtD
Trimipramine—Decreased appetite—Capecitabine—stomach cancer	0.000216	0.00141	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—stomach cancer	0.000215	0.0014	CcSEcCtD
Trimipramine—Fatigue—Capecitabine—stomach cancer	0.000214	0.0014	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—stomach cancer	0.000213	0.00139	CcSEcCtD
Trimipramine—Constipation—Capecitabine—stomach cancer	0.000212	0.00139	CcSEcCtD
Trimipramine—Feeling abnormal—Docetaxel—stomach cancer	0.000211	0.00138	CcSEcCtD
Trimipramine—Nausea—Fluorouracil—stomach cancer	0.000211	0.00138	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—stomach cancer	0.00021	0.00137	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—stomach cancer	0.00021	0.00137	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—stomach cancer	0.000209	0.00136	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—stomach cancer	0.000208	0.00135	CcSEcCtD
Trimipramine—Feeling abnormal—Capecitabine—stomach cancer	0.000205	0.00133	CcSEcCtD
Trimipramine—Malaise—Methotrexate—stomach cancer	0.000204	0.00133	CcSEcCtD
Trimipramine—Mianserin—HTR1A—stomach cancer	0.000203	0.0318	CrCbGaD
Trimipramine—Abdominal pain—Docetaxel—stomach cancer	0.000203	0.00132	CcSEcCtD
Trimipramine—Body temperature increased—Docetaxel—stomach cancer	0.000203	0.00132	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—stomach cancer	0.000201	0.00131	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—stomach cancer	0.0002	0.0013	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—stomach cancer	0.000199	0.0013	CcSEcCtD
Trimipramine—Urticaria—Capecitabine—stomach cancer	0.000197	0.00129	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—stomach cancer	0.000197	0.00128	CcSEcCtD
Trimipramine—Body temperature increased—Capecitabine—stomach cancer	0.000196	0.00128	CcSEcCtD
Trimipramine—Abdominal pain—Capecitabine—stomach cancer	0.000196	0.00128	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—stomach cancer	0.000196	0.00128	CcSEcCtD
Trimipramine—Agitation—Epirubicin—stomach cancer	0.000195	0.00127	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—stomach cancer	0.000192	0.00125	CcSEcCtD
Trimipramine—Malaise—Epirubicin—stomach cancer	0.000191	0.00125	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—stomach cancer	0.000191	0.00124	CcSEcCtD
Trimipramine—Palpitations—Epirubicin—stomach cancer	0.000187	0.00122	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—stomach cancer	0.000186	0.00122	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—stomach cancer	0.000185	0.00121	CcSEcCtD
Trimipramine—Asthenia—Docetaxel—stomach cancer	0.000184	0.0012	CcSEcCtD
Trimipramine—Convulsion—Epirubicin—stomach cancer	0.000184	0.0012	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—stomach cancer	0.000183	0.00119	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000182	0.00119	CcSEcCtD
Trimipramine—Nortriptyline—HTR1A—stomach cancer	0.000182	0.0284	CrCbGaD
Trimipramine—Pruritus—Docetaxel—stomach cancer	0.000181	0.00118	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—stomach cancer	0.000181	0.00118	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—stomach cancer	0.00018	0.00118	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—stomach cancer	0.00018	0.00117	CcSEcCtD
Trimipramine—ABCB1—lymph node—stomach cancer	0.000179	0.00221	CbGeAlD
Trimipramine—Discomfort—Epirubicin—stomach cancer	0.000178	0.00116	CcSEcCtD
Trimipramine—Asthenia—Capecitabine—stomach cancer	0.000178	0.00116	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—stomach cancer	0.000177	0.00115	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—stomach cancer	0.000177	0.00115	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—stomach cancer	0.000176	0.00115	CcSEcCtD
Trimipramine—Pruritus—Capecitabine—stomach cancer	0.000176	0.00115	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—stomach cancer	0.000176	0.00114	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—stomach cancer	0.000174	0.00114	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—stomach cancer	0.000173	0.00113	CcSEcCtD
Trimipramine—Oedema—Epirubicin—stomach cancer	0.000173	0.00113	CcSEcCtD
Trimipramine—Hypotension—Methotrexate—stomach cancer	0.000173	0.00113	CcSEcCtD
Trimipramine—Desipramine—CYP2A6—stomach cancer	0.000172	0.027	CrCbGaD
Trimipramine—Convulsion—Doxorubicin—stomach cancer	0.00017	0.00111	CcSEcCtD
Trimipramine—Diarrhoea—Capecitabine—stomach cancer	0.00017	0.00111	CcSEcCtD
Trimipramine—Dizziness—Docetaxel—stomach cancer	0.00017	0.00111	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—stomach cancer	0.000169	0.0011	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—stomach cancer	0.000169	0.0011	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—stomach cancer	0.000169	0.0011	CcSEcCtD
Trimipramine—Desipramine—ADRB1—stomach cancer	0.000167	0.0262	CrCbGaD
Trimipramine—Insomnia—Methotrexate—stomach cancer	0.000167	0.00109	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—stomach cancer	0.000166	0.00109	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—stomach cancer	0.000166	0.00108	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—stomach cancer	0.000165	0.00108	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—stomach cancer	0.000165	0.00108	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—stomach cancer	0.000164	0.00107	CcSEcCtD
Trimipramine—Dizziness—Capecitabine—stomach cancer	0.000164	0.00107	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—stomach cancer	0.000163	0.00107	CcSEcCtD
Trimipramine—Doxepin—HTR1A—stomach cancer	0.000163	0.0255	CrCbGaD
Trimipramine—Vomiting—Docetaxel—stomach cancer	0.000163	0.00106	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—stomach cancer	0.000163	0.00106	CcSEcCtD
Trimipramine—Rash—Docetaxel—stomach cancer	0.000162	0.00105	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—stomach cancer	0.000162	0.00105	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—stomach cancer	0.000162	0.00105	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—stomach cancer	0.000161	0.00105	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—stomach cancer	0.000161	0.00105	CcSEcCtD
Trimipramine—Headache—Docetaxel—stomach cancer	0.000161	0.00105	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—stomach cancer	0.00016	0.00104	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—stomach cancer	0.000159	0.00104	CcSEcCtD
Trimipramine—Vomiting—Capecitabine—stomach cancer	0.000158	0.00103	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000157	0.00102	CcSEcCtD
Trimipramine—Rash—Capecitabine—stomach cancer	0.000157	0.00102	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—stomach cancer	0.000156	0.00102	CcSEcCtD
Trimipramine—Dermatitis—Capecitabine—stomach cancer	0.000156	0.00102	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—stomach cancer	0.000156	0.00102	CcSEcCtD
Trimipramine—Headache—Capecitabine—stomach cancer	0.000156	0.00101	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—stomach cancer	0.000155	0.00101	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—stomach cancer	0.000154	0.001	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—stomach cancer	0.000153	0.000995	CcSEcCtD
Trimipramine—Nausea—Docetaxel—stomach cancer	0.000152	0.000994	CcSEcCtD
Trimipramine—Feeling abnormal—Methotrexate—stomach cancer	0.000152	0.000994	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—stomach cancer	0.000152	0.000993	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—stomach cancer	0.00015	0.000981	CcSEcCtD
Trimipramine—Desipramine—HTR1A—stomach cancer	0.00015	0.0234	CrCbGaD
Trimipramine—Hypotension—Doxorubicin—stomach cancer	0.00015	0.000976	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—stomach cancer	0.000149	0.000973	CcSEcCtD
Trimipramine—Constipation—Epirubicin—stomach cancer	0.000148	0.000965	CcSEcCtD
Trimipramine—Nausea—Capecitabine—stomach cancer	0.000148	0.000962	CcSEcCtD
Trimipramine—Urticaria—Methotrexate—stomach cancer	0.000147	0.000958	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—stomach cancer	0.000146	0.000953	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—stomach cancer	0.000146	0.000953	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—stomach cancer	0.000145	0.0228	CrCbGaD
Trimipramine—Insomnia—Doxorubicin—stomach cancer	0.000145	0.000944	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—stomach cancer	0.000144	0.000938	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—stomach cancer	0.000143	0.00093	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—stomach cancer	0.000142	0.000928	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—stomach cancer	0.000141	0.000919	CcSEcCtD
Trimipramine—Desipramine—ADRB2—stomach cancer	0.000141	0.022	CrCbGaD
Trimipramine—Decreased appetite—Doxorubicin—stomach cancer	0.000139	0.000908	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—stomach cancer	0.000138	0.0009	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—stomach cancer	0.000137	0.000896	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—stomach cancer	0.000137	0.000893	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—stomach cancer	0.000137	0.000892	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—stomach cancer	0.000137	0.000892	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—stomach cancer	0.000133	0.000865	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—stomach cancer	0.000132	0.00086	CcSEcCtD
Trimipramine—Pruritus—Methotrexate—stomach cancer	0.000131	0.000853	CcSEcCtD
Trimipramine—Chlorpromazine—HTR1A—stomach cancer	0.000128	0.02	CrCbGaD
Trimipramine—Urticaria—Doxorubicin—stomach cancer	0.000127	0.000829	CcSEcCtD
Trimipramine—Imipramine—HTR1A—stomach cancer	0.000127	0.0199	CrCbGaD
Trimipramine—Body temperature increased—Doxorubicin—stomach cancer	0.000127	0.000825	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—stomach cancer	0.000127	0.000825	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—stomach cancer	0.000126	0.000825	CcSEcCtD
Trimipramine—Amitriptyline—HTR1A—stomach cancer	0.000126	0.0197	CrCbGaD
Trimipramine—Asthenia—Epirubicin—stomach cancer	0.000124	0.00081	CcSEcCtD
Trimipramine—Pruritus—Epirubicin—stomach cancer	0.000122	0.000798	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—stomach cancer	0.000122	0.000797	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—stomach cancer	0.000118	0.000772	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—stomach cancer	0.000118	0.000767	CcSEcCtD
Trimipramine—Rash—Methotrexate—stomach cancer	0.000117	0.00076	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—stomach cancer	0.000116	0.00076	CcSEcCtD
Trimipramine—Headache—Methotrexate—stomach cancer	0.000116	0.000755	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—stomach cancer	0.000115	0.000749	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—stomach cancer	0.000114	0.000746	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—stomach cancer	0.000113	0.000739	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—stomach cancer	0.00011	0.000717	CcSEcCtD
Trimipramine—Acepromazine—ALB—stomach cancer	0.00011	0.0172	CrCbGaD
Trimipramine—Nausea—Methotrexate—stomach cancer	0.00011	0.000716	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—stomach cancer	0.00011	0.000714	CcSEcCtD
Trimipramine—Rash—Epirubicin—stomach cancer	0.000109	0.000711	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—stomach cancer	0.000109	0.000711	CcSEcCtD
Trimipramine—Headache—Epirubicin—stomach cancer	0.000108	0.000707	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—stomach cancer	0.000106	0.00069	CcSEcCtD
Trimipramine—Nausea—Epirubicin—stomach cancer	0.000103	0.00067	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—stomach cancer	0.000102	0.000664	CcSEcCtD
Trimipramine—Rash—Doxorubicin—stomach cancer	0.000101	0.000658	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—stomach cancer	0.000101	0.000658	CcSEcCtD
Trimipramine—Headache—Doxorubicin—stomach cancer	0.0001	0.000654	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—stomach cancer	9.51e-05	0.00062	CcSEcCtD
Trimipramine—Clomipramine—ALB—stomach cancer	8.35e-05	0.0131	CrCbGaD
Trimipramine—Nortriptyline—ALB—stomach cancer	8.16e-05	0.0128	CrCbGaD
Trimipramine—Chlorpromazine—ALB—stomach cancer	5.73e-05	0.00896	CrCbGaD
Trimipramine—Amitriptyline—ALB—stomach cancer	5.66e-05	0.00886	CrCbGaD
Trimipramine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	5.31e-06	4.12e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	5.29e-06	4.11e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RHOA—stomach cancer	5.28e-06	4.1e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RHOA—stomach cancer	5.27e-06	4.1e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MTHFR—stomach cancer	5.27e-06	4.09e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK1—stomach cancer	5.26e-06	4.09e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EGFR—stomach cancer	5.26e-06	4.09e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	5.24e-06	4.07e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOS3—stomach cancer	5.23e-06	4.06e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	5.22e-06	4.06e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	5.22e-06	4.06e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOS3—stomach cancer	5.22e-06	4.05e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	5.22e-06	4.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—stomach cancer	5.2e-06	4.04e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CAV1—stomach cancer	5.2e-06	4.04e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOA1—stomach cancer	5.19e-06	4.03e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	5.18e-06	4.03e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	5.17e-06	4.02e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—JUN—stomach cancer	5.17e-06	4.02e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CD44—stomach cancer	5.13e-06	3.99e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	5.12e-06	3.98e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	5.11e-06	3.97e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—stomach cancer	5.11e-06	3.97e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.09e-06	3.96e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	5.08e-06	3.95e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—stomach cancer	5.08e-06	3.95e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	5.06e-06	3.93e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	5.03e-06	3.91e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	5.01e-06	3.89e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—stomach cancer	5e-06	3.89e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	4.99e-06	3.88e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—JUN—stomach cancer	4.99e-06	3.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.99e-06	3.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	4.98e-06	3.87e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	4.98e-06	3.87e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—stomach cancer	4.98e-06	3.87e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB2—stomach cancer	4.97e-06	3.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	4.97e-06	3.86e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KRAS—stomach cancer	4.97e-06	3.86e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—JUN—stomach cancer	4.97e-06	3.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	4.93e-06	3.83e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CAV1—stomach cancer	4.9e-06	3.81e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	4.89e-06	3.8e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOA1—stomach cancer	4.89e-06	3.8e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	4.89e-06	3.8e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB2—stomach cancer	4.88e-06	3.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	4.88e-06	3.79e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	4.86e-06	3.78e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CAV1—stomach cancer	4.86e-06	3.78e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—stomach cancer	4.86e-06	3.77e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOA1—stomach cancer	4.85e-06	3.77e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	4.84e-06	3.76e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—stomach cancer	4.83e-06	3.75e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	4.81e-06	3.74e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	4.81e-06	3.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	4.79e-06	3.72e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	4.76e-06	3.7e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	4.76e-06	3.7e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—JUN—stomach cancer	4.75e-06	3.69e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	4.72e-06	3.67e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL8—stomach cancer	4.72e-06	3.66e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	4.7e-06	3.65e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PPARG—stomach cancer	4.69e-06	3.64e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—stomach cancer	4.68e-06	3.64e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.64e-06	3.61e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	4.64e-06	3.6e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL8—stomach cancer	4.63e-06	3.6e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	4.63e-06	3.59e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	4.61e-06	3.58e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	4.61e-06	3.58e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	4.6e-06	3.58e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—stomach cancer	4.6e-06	3.57e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—stomach cancer	4.58e-06	3.55e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	4.57e-06	3.55e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	4.54e-06	3.53e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	4.53e-06	3.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	4.53e-06	3.52e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	4.52e-06	3.51e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	4.52e-06	3.51e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	4.51e-06	3.51e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	4.5e-06	3.49e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—stomach cancer	4.48e-06	3.48e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	4.47e-06	3.47e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	4.45e-06	3.46e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	4.44e-06	3.45e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—stomach cancer	4.42e-06	3.43e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—stomach cancer	4.41e-06	3.43e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—stomach cancer	4.4e-06	3.42e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—stomach cancer	4.39e-06	3.41e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—stomach cancer	4.38e-06	3.4e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.36e-06	3.39e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	4.36e-06	3.39e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	4.34e-06	3.37e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—stomach cancer	4.32e-06	3.36e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	4.32e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—stomach cancer	4.32e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—stomach cancer	4.31e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—stomach cancer	4.31e-06	3.35e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—stomach cancer	4.31e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—stomach cancer	4.3e-06	3.34e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—stomach cancer	4.3e-06	3.34e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—stomach cancer	4.28e-06	3.32e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	4.27e-06	3.32e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—stomach cancer	4.27e-06	3.32e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—stomach cancer	4.26e-06	3.31e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	4.25e-06	3.3e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	4.23e-06	3.29e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—stomach cancer	4.23e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—stomach cancer	4.22e-06	3.28e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HMOX1—stomach cancer	4.22e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	4.22e-06	3.28e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—stomach cancer	4.21e-06	3.27e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—stomach cancer	4.2e-06	3.26e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	4.19e-06	3.26e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—stomach cancer	4.19e-06	3.25e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	4.18e-06	3.25e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	4.17e-06	3.24e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—stomach cancer	4.16e-06	3.23e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	4.15e-06	3.23e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK8—stomach cancer	4.15e-06	3.22e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	4.13e-06	3.2e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	4.12e-06	3.2e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—stomach cancer	4.11e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	4.11e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	4.11e-06	3.19e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	4.1e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	4.09e-06	3.18e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	4.08e-06	3.17e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK8—stomach cancer	4.07e-06	3.16e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	4.07e-06	3.16e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	4.07e-06	3.16e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—stomach cancer	4.04e-06	3.14e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NOS3—stomach cancer	4.03e-06	3.13e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	4.01e-06	3.12e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—stomach cancer	4.01e-06	3.12e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	4e-06	3.1e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—stomach cancer	3.99e-06	3.1e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TYMS—stomach cancer	3.98e-06	3.09e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NOS3—stomach cancer	3.94e-06	3.06e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—stomach cancer	3.93e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	3.93e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	3.93e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	3.93e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—stomach cancer	3.93e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—stomach cancer	3.92e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	3.91e-06	3.03e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—stomach cancer	3.9e-06	3.03e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—stomach cancer	3.88e-06	3.01e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—stomach cancer	3.84e-06	2.98e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	3.84e-06	2.98e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—stomach cancer	3.83e-06	2.97e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—stomach cancer	3.82e-06	2.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	3.82e-06	2.96e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	3.8e-06	2.95e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—stomach cancer	3.79e-06	2.94e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	3.77e-06	2.93e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—stomach cancer	3.76e-06	2.92e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	3.74e-06	2.9e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	3.74e-06	2.9e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—stomach cancer	3.73e-06	2.9e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—stomach cancer	3.72e-06	2.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.71e-06	2.88e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NOS3—stomach cancer	3.71e-06	2.88e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.71e-06	2.88e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ERCC2—stomach cancer	3.7e-06	2.87e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.69e-06	2.87e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—stomach cancer	3.69e-06	2.86e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—stomach cancer	3.69e-06	2.86e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NOS3—stomach cancer	3.68e-06	2.85e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.65e-06	2.84e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—stomach cancer	3.62e-06	2.81e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—stomach cancer	3.6e-06	2.8e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	3.56e-06	2.77e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—stomach cancer	3.56e-06	2.76e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	3.53e-06	2.74e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	3.53e-06	2.74e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—stomach cancer	3.52e-06	2.74e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	3.49e-06	2.71e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—stomach cancer	3.48e-06	2.7e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—stomach cancer	3.47e-06	2.69e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—stomach cancer	3.46e-06	2.69e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.45e-06	2.68e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—stomach cancer	3.45e-06	2.68e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	3.43e-06	2.66e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—stomach cancer	3.41e-06	2.65e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.41e-06	2.65e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—stomach cancer	3.39e-06	2.64e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	3.39e-06	2.64e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	3.39e-06	2.63e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—stomach cancer	3.39e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—stomach cancer	3.39e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	3.39e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK1—stomach cancer	3.38e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—stomach cancer	3.38e-06	2.63e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—stomach cancer	3.36e-06	2.61e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	3.32e-06	2.58e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	3.32e-06	2.58e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—stomach cancer	3.3e-06	2.56e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—stomach cancer	3.28e-06	2.55e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	3.26e-06	2.54e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—stomach cancer	3.26e-06	2.53e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	3.24e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	3.24e-06	2.52e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CAV1—stomach cancer	3.21e-06	2.49e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—stomach cancer	3.2e-06	2.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—stomach cancer	3.2e-06	2.49e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOA1—stomach cancer	3.2e-06	2.48e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—stomach cancer	3.2e-06	2.48e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—stomach cancer	3.15e-06	2.45e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—stomach cancer	3.15e-06	2.45e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—stomach cancer	3.14e-06	2.44e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	3.14e-06	2.44e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—stomach cancer	3.14e-06	2.44e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—stomach cancer	3.12e-06	2.43e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	3.09e-06	2.4e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	3.09e-06	2.4e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—stomach cancer	3.02e-06	2.34e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	3e-06	2.33e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—stomach cancer	3e-06	2.33e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.99e-06	2.32e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.94e-06	2.29e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.94e-06	2.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	2.91e-06	2.26e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—stomach cancer	2.89e-06	2.25e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.88e-06	2.24e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—stomach cancer	2.87e-06	2.23e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—stomach cancer	2.85e-06	2.21e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—stomach cancer	2.84e-06	2.21e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—stomach cancer	2.82e-06	2.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.79e-06	2.17e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—stomach cancer	2.77e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.72e-06	2.11e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—stomach cancer	2.72e-06	2.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.68e-06	2.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.67e-06	2.07e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—stomach cancer	2.65e-06	2.06e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—stomach cancer	2.61e-06	2.02e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—stomach cancer	2.6e-06	2.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.59e-06	2.01e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.55e-06	1.98e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—stomach cancer	2.53e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.48e-06	1.92e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NOS3—stomach cancer	2.42e-06	1.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.37e-06	1.84e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.27e-06	1.76e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—stomach cancer	2.22e-06	1.72e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—stomach cancer	2.21e-06	1.72e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.09e-06	1.62e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.07e-06	1.61e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.36e-06	1.06e-05	CbGpPWpGaD
